Skip to main content

Coronary SS sirolimus-eluting stent

The sirolimus-eluting SS coronary stent is indicated for de novo and in-stent lesions in native coronary arteries, offering an effective solution for patients with acute coronary syndrome, MI, or diabetes mellitus.

Coronary SS sirolimus-eluting stent

The sirolimus-eluting SS coronary stent is indicated for de novo and in-stent lesions in native coronary arteries, offering an effective solution for patients with acute coronary syndrome, MI, or diabetes mellitus.


The SS coronary stent is a balloon-expandable device made from 316L stainless steel, with a sirolimus coating to improve the luminal diameter and reduce restenosis within and at the edges of the stent. It’s indicated for the treatment of restenotic lesions in patients with coronary artery disease, including those with acute myocardial infarction, unstable angina, or diabetes mellitus. Its rapid exchange delivery system and low-profile design ensure efficient and precise implantation.

Features

     

  • Material: 316L Stainless Steel
  •  

  • Stent Diameter: 2.0 mm – 5.0 mm
  •  

  • Stent Length: 8 mm – 40 mm
  •  

  • Stent Thickness: 0.115 mm
  •  

  • Delivery System: Rapid Exchange
  •  

  • Minimum Sheath Diameter: 6 Fr / 2.0 mm
  •  

  • Usable Catheter: 140 cm
  •  

  • Compatible Guidewire: 0.014″
  •  

  • Stent Crimped Profile: 0.038″
  •  

  • Design: SS Laser Cut
  •  

  • Nominal Pressure: 8 – 10 atm
  •  

  • Rated Burst Pressure: 20 atm
  •  

  • Balloon Deflation Time: <60 s
  •  

  • Drug: Sirolimus 1 µg/mm²

Benefits

     

  • Effective reduction of in-stent and edge restenosis
  •  

  • Increased post-procedure luminal diameter
  •  

  • High compatibility with complex coronary anatomies
  •  

  • Low-profile design facilitating access and placement
  •  

  • Broad indications for patients with acute and chronic coronary diseases
  •  

  • Controlled sirolimus release reducing hyperplasia
stent coronario cocr liberador de sirolimus atlas 2 biogen
stent coronario cocr liberador de sirolimus atlas 3 biogen